Details for Patent: 9,669,974

Which drugs does patent 9,669,974 protect, and when does it expire?

Patent 9,669,974 protects RESTASIS MULTIDOSE and is included in one NDA.

This patent has twenty-five patent family members in twenty-two countries.

Summary for Patent: 9,669,974

Title:	Protective cap for a dispenser, and discharge device for discharging pharmaceutical and/or cosmetical liquids
Abstract:	The invention relates to a protective cap for a dispenser, and to a dispenser for discharging pharmaceutical and/or cosmetical liquids, wherein the dispenser has a liquid reservoir and an outlet opening through which the liquid can be discharged into a surrounding atmosphere. The protective cap comprises an outer cap and an inner element inserted therein, wherein either at least one ventilation channel, which can be closed by means of a shut-off element and provides communication between an interior of the protective cap and an external environment, is formed between the outer cap and the inner element, or the inner element closes a ventilation opening of the outer cap.
Inventor(s):	Wochele; Matthias (Rielasingen-Worblingen, DE), Mallare; Antonio O. (Gardena, CA), Shankar; Sai (Irvine, CA)
Assignee:	APTAR RADOLFZELL GMBH (Radolfzell, DE)
Application Number:	14/108,449
Patent Claim Types: see list of patent claims	Use; Device;

Drugs Protected by US Patent 9,669,974

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Abbvie	RESTASIS MULTIDOSE	cyclosporine	EMULSION;OPHTHALMIC	050790-002	Oct 27, 2016		RX	Yes	Yes			Y

International Family Members for US Patent 9,669,974

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014368818
Brazil	112016013690
Canada	2933069
China	105813949
Germany	102014201697